Bruce H. Davis, M.D.
Founder and President of Trillium Diagnostics, is a Hematopathologist, who received his education at Cornell University (B.S.) and University of Connecticut (M.D.). He started his academic career at Upstate-SUNY Medical Center in Syracuse, NY where he developed his interest in flow cytometry as a diagnostic tool in medicine. He then moved to Dartmouth-Hitchcock Medical Center, where he published extensively on reticulocyte analysis by flow cytometry and developed the diagnostic concept of the immature reticulocyte fraction, which is now a standard diagnostic parameter in anemia assessment in laboratory hematology. His research at Dartmouth also included the diagnostic utility of neutrophil CD64 for infection and sepsis. Dr. Davis co-founded with the late Dr. Berend Houwen from Groningen. NL the International Society for Laboratory Hematology and the journal Laboratory Hematology. Dr. Davis was Director of Flow Cytometry at William Beaumont Hospital in Michigan during 1994 – 2000; there he developed the first FDA-cleared method for fetomaternal hemorrhage detection using a flow cytometric technique with anti-HbF monoclonal antibodies. He has been active in numerous professional organizations and societies, having served as President for the Clinical Cytometry Society, Treasurer and Board member for the International Society for Laboratory Hematology, member of the Hematology Resource Committee for the College of American Pathologists, Treasurer for the International Committee for the Standardization of Haematology, and Chair of the area committee on hematology for CLSI (formerly NCCLS). He has over 100 peer-reviewed publications and serves on the editorial boards for journals of cytometry and laboratory hematology and has provided consultation to a number of medical diagnostic companies. Dr. Davis returned to his native New England at the turn of the century to establish Trillium Diagnostic, LLC, from which he continues his consulting activities, research and development of new diagnostic products for laboratory hematology, and works to establish acceptance of Leuko64 as a superior diagnostic assay for the detection of infection and sepsis.
Naomi B. Culp, DA, MT(ASCP)SH
Manager, Clinical Trials and Scientific Affairs
Naomi joined Trillium Diagnostics after extensive experience in the Laboratory Hematology industry. She earned her BS in Medical Technology from Thomas Jefferson University in Philadelphia, PA, her MS in Biology and Doctor of Arts in Medical Technology from The Catholic University of America, Washington, DC. Her career has included teaching in the medical technology program at Wichita State University, and working in hematology labs in New Jersey and the Boston area. Her industry experience began at Scientific Products/Baxter Healthcare and continued at companies such as Sysmex Corporation, Sigma Diagnostics, Beckman Coulter and Constitution Medical Inc./Bloodhound. She is a member of ISLH, AACC, ACRP and incoming Treasurer of ICSH. She participates on the CLSI Consensus Committee on Hematology.
Adam Curtis, M.S.
Manager of Product Development
Adam joined Trillium Diagnostics as Manager of Product Development after working as the manager of the flow cytometry facility at the Maine Institute for Human Genetics and Health in Bangor, Maine. Before coming to the Maine Institute for Human Genetics and Health, Adam gained experience in the field of monoclonal antibody development and clinical diagnostics while at Maine Biotechnology Services, in Portland, Maine. Prior to that, Adam taught high school biology, and earned a Masters degree in Immunology from the University of Southern Maine and a B.S. in Aquatic Sciences from the University of Maine.
Barbara G. Kershner, MSB, PHR
Manager, Operations and Quality Systems
Barbara joined the team in 2010 as the Manger of Operations and Quality Systems after working for over 4 years at the Maine Institute for Human Genetics & Health at Eastern Maine Healthcare Systems as their Human Resource Specialist and prior to that working for 14 years with Dr. Clifford J. Rosen at the Maine Center for Osteoporosis Research and Education at St. Joseph Hospital. She states that she has thoroughly enjoyed her careers within the relatively small Bangor / Brewer community as they both were centered around research and working with people. Barbara originally graduated from Champlain College with her Paralegal degree but then returned to further her education and received her MSB from Husson University in 2007. She enjoys her daily communication with collaborators, customers and the community in general and is always eager to help in any way. Barbara has 2 children and enjoys spending time with her family and her cats.
Anthony J Carcio, MLS (ASCP)
Research & Development Scientist
Anthony joined Trillium Diagnostics after graduating from the University of Connecticut in May of 2011 with a Bachelor’s degree in Medical Technology. Before graduating, he conducted his clinical rotation through the laboratory at The University of Connecticut Health Center in Farmington, CT. Anthony has worked previously as a phlebotomist at the Charlotte Hungerford Hospital in Plainville, CT while still attending college. Anthony recently returned from the International Society of Laboratory Hematology meeting in Nice, France where he gave his first presentation on one of Trillium’s current projects.
Linda joined Trillium Diagnostics as a part-time QA/QC laboratory assistant during her sophomore year of college. She completed a poster depicting an improved method for high purity monocyte gating by flow cytometry that was presented at the 2011 ICCS Meeting. Linda graduated Phi Beta Kappa and summa cum laude with a bachelor's degree in Biology and Spanish from the University of Maine in 2012. Upon graduation, she began working as a research assistant and safety officer at Trillium.